PremiumCompany AnnouncementsSynairgen Strengthens Board with Appointment of Martin Murphy Synairgen Secures £18 Million for Phase 2 Trial of SNG001 Synairgen Launches Fundraising to Advance Respiratory Treatment Trials PremiumCompany AnnouncementsSynairgen Announces Upcoming Board Changes Synairgen Prioritizes SNG001 Development, Eyes Phase 2 Trial